Madison, WI 的 胃癌 臨床試驗
11 項針對 胃癌 的研究正在 Madison(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
招募中2 期
- UW Health Carbone Cancer Center, Madison
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
招募中2/3 期
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
招募中3 期
- University of Wisconsin Carbone Cancer Center, Madison
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
招募中2 期
- Research Site, Madison
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
招募中1 期
- University of Wisconsin - Carbone Cancer Center, Madison
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
招募中1/2 期
- The Board of Regents of the University of Wisconsin, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- University of Wisconsin- Madison, Madison
Lead-212 PSV359 Therapy for Patients With Solid Tumors
招募中1/2 期
- University of Wisconsin, Madison
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
招募中1 期
- UW Carbone Cancer Center, Madison
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
招募中2 期
- University of Wisconsin, Madison
其他城市的 胃癌 試驗
- Houston, TX42 項研究
- Boston, MA32 項研究
- New York City, NY31 項研究
- Nashville, TN28 項研究
- Baldwin Park, CA22 項研究
- Los Angeles, CA22 項研究
- Arlington, VA20 項研究
- Dallas, TX19 項研究
- San Antonio, TX19 項研究
- St. Louis, MO18 項研究
- Grand Rapids, MI18 項研究
- Chicago, IL16 項研究
Madison 的其他研究
- 前列腺癌29 項研究
- 大腸直腸癌23 項研究
- 乳癌22 項研究
- 轉移性癌症21 項研究
- 急性髓系白血病16 項研究
- 非小細胞肺癌16 項研究
- 黑色素瘤15 項研究
- 癌症(所有類型)14 項研究
- 卵巢癌13 項研究
- 胰臟癌10 項研究
- 肺癌10 項研究
- 多發性骨髓瘤9 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。